Skip to main content

Dr. Hans M. Sander, MD

Dermatology (Dermatology Physician)

  • Medicare participating

At a glance

Years since graduation
43
In the NPI registry since
2005
Medicare patients seen, 2024
734

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1983Medical school: Texas A & M University System, Hsc, College of Medicine
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Dermatology Physician primary

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Dermatology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
734
Services billed
5,469
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Destruction of precancer skin growth, 2-14 growths1,937324
Established patient office or other outpatient visit, 20-29 minutes746525
Destruction of precancer skin growth, 1 growth629457
Established patient office or other outpatient visit, 30-39 minutes450280
Biopsy of related skin growth, first growth362295
Destruction of skin growth, 1-14 growths208179
Biopsy of related skin growth, each additional growth16789
Injection, triamcinolone acetonide, not otherwise specified, 10 mg9553
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm7871
Injection of drug or substance under skin or into muscle6215

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 24 companies reported 286 payments worth $5,842 in total to this clinician.

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jul 9, 2025Janssen Biotech, Inc.
Jul 9, 2025
Education
TREMFYA · Immunology · in-kind
$54.99

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $72,132 in research payments for these studies, mostly to the institutions running them.

  • The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
    Incyte Corporation
  • A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASC…
    Amgen Inc.
  • Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
    Sanofi US Services Inc. · Terminated · NCT06058156

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Dermatology clinicians in Austin

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 8, 2017), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1285635813. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.